Alantolactone pyrazoline analogue inhibits cancer cell proliferation and induces apoptosis in non-small cell lung carcinoma cells

Alantolactone pyrazoline analogue inhibits cancer cell proliferation and induces apoptosis in non-small cell lung carcinoma cells

The aim of the current study was to evaluate the anticancer and apoptotic effects of alantolactone pyrazoline analogue in human non-small cell lung cancer (NCI-H460) cells. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide) assay was used to evaluate the cell viability while as fluo...

Full description

Bibliographic Details
Main Authors:	Jing lv, Ming-Qin Cao, Jian-Chun Yu
Format:	Article
Language:	English
Published:	Bangladesh Pharmacological Society 2015-05-01
Series:	Bangladesh Journal of Pharmacology
Subjects:	Alantolactone pyrazoline analogue Anti-cancer Apoptosis Cell cycle Lung cancer
Online Access:	https://www.banglajol.info/index.php/BJP/article/view/22619

Similar Items

Alantolactone and ZnO nanoparticles induce apoptosis activity of cisplatin in an ovarian cancer cell line (SKOV3)
by: Shahriar Alipour, et al.
Published: (2022-01-01)

Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
by: Xing Kang, et al.
Published: (2019-12-01)

Alantolactone induces platelet apoptosis by activating the Akt pathway
by: Yueyue Sun, et al.
Published: (2023-12-01)

Alantolactone inhibits stem-like cell phenotype, chemoresistance and metastasis in PC3 cells through STAT3 signaling pathway
by: Ghader Babaei, et al.
Published: (2020-01-01)

Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
by: Yahui Ding, et al.
Published: (2016-09-01)

Alantolactone triggers oxeiptosis in human ovarian cancer cells via Nrf2 signaling pathway
by: Mahdieh Nasirzadeh, et al.
Published: (2023-09-01)

Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia
by: Ce Shi, et al.
Published: (2020-09-01)

Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways
by: Chunmei Yang, et al.
Published: (2022-03-01)

Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
by: Zhiwen Fu, et al.
Published: (2022-03-01)

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
by: Yuan Cai, et al.
Published: (2021-11-01)

Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways
by: Xiaomin Dang, et al.
Published: (2020-04-01)

Triggering of Programmed Erythrocyte Death by Alantolactone
by: Kousi Alzoubi, et al.
Published: (2014-12-01)

Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment
by: Ruijie Chen, et al.
Published: (2022-03-01)

The Hepatotoxicity of Alantolactone and Germacrone: Their Influence on Cholesterol and Lipid Metabolism in Differentiated HepaRG Cells
by: Tomáš Zárybnický, et al.
Published: (2020-06-01)

The Effect of Alantolactone on the Development of Multiple Sclerosis
by: Mustafa Cakir, et al.
Published: (2019-12-01)

New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study
by: Mariam M. Fakhry, et al.
Published: (2023-11-01)

Alantolactone Enhances the Phagocytic Properties of Human Macrophages and Modulates Their Proinflammatory Functions
by: Barbara Gierlikowska, et al.
Published: (2020-09-01)

Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line
by: Weijie Xu, et al.
Published: (2017-03-01)

Alantolactone: A Potential Multitarget Drug candidate for Prevention of SARS-CoV-2 Cell Entry
by: Erum Zafar, et al.
Published: (2022-12-01)

Semisynthesis, an Anti-Inflammatory Effect of Derivatives of 1β-Hydroxy Alantolactone from Inula britannica
by: Lin Chen, et al.
Published: (2017-10-01)

Antifungal effects of alantolactone on Candida albicans: An in vitro study
by: Longfei Yang, et al.
Published: (2022-05-01)

Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents
by: Muhammed Karabacak, et al.
Published: (2015-10-01)

Pharmacokinetics, Tissue Distribution and Excretion of Isoalantolactone and Alantolactone in Rats after Oral Administration of Radix Inulae Extract
by: Renjie Xu, et al.
Published: (2015-04-01)

Ultrasound-assisted Synthesis of Some New Curcumin Analogues and Their Corresponding Pyrazoline Derivatives
by: Farouq E. Hawaiz, et al.
Published: (2017-05-01)

Synthesis of New Pyrazoline - Phenoxathiin Derivatives
by: Baghdad Science Journal
Published: (2013-06-01)

Molecular Docking study, and In vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone against breast cancer cell line (MCF-7)
by: Kanar Muthanna Alawad, et al.
Published: (2022-10-01)

A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells
by: Mustofa, et al.
Published: (2022-07-01)

Design, Synthesis, In Silico ADMET Studies and Anticancer Activity of Some New Pyrazoline and Benzodioxole Derivatives
by: Fatih Tok, et al.
Published: (2022-06-01)

Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
by: Mariam M. Fakhry, et al.
Published: (2022-10-01)

Cytotoxicity and Apoptosis Effects of Curcumin Analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) Cyclohexanone (DMCH) on Human Colon Cancer Cells HT29 and SW620 In Vitro
by: Nurul Fattin Che Rahim, et al.
Published: (2021-02-01)

Synthesis of Some New Pyrazolines
by: A.J. AL-Hamdany, et al.
Published: (2006-03-01)

Alantolactone Suppresses Proliferation and the Inflammatory Response in Human HaCaT Keratinocytes and Ameliorates Imiquimod-Induced Skin Lesions in a Psoriasis-Like Mouse Model
by: Wen-Ho Chuo, et al.
Published: (2021-06-01)

Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAF<sup>V600E</sup> Inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2023-05-01)

Synthesis of New Pyrazolines Derivatives from Coumarine Compounds
by: W. Gh-Bedewy, et al.
Published: (1999-11-01)

Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition
by: Malgorzata Jozkowiak, et al.
Published: (2021-06-01)

Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines
by: Halise Inci Gul, et al.
Published: (2017-01-01)

Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAF<sup>V600E</sup> Inhibitory Pathways
by: Lamya H. Al-Wahaibi, et al.
Published: (2023-09-01)

Elecampane (<i>Inula helenium</i>) Root Extract and Its Major Sesquiterpene Lactone, Alantolactone, Inhibit Adipogenesis of 3T3-L1 Preadipocytes
by: Yeon-Seop Jung, et al.
Published: (2022-07-01)

De Novo Design of Imidazopyridine-Tethered Pyrazolines That Target Phosphorylation of STAT3 in Human Breast Cancer Cells
by: Akshay Ravish, et al.
Published: (2023-01-01)

Synthesis and Characterization of Some New Pyrazoline and Isoxazoline Derivatives as Antibacterial Agents
by: Baghdad Science Journal
Published: (2016-09-01)